Hazlett, Burt & Watson, Inc. Moderna, Inc. Transaction History

Hazlett, Burt & Watson, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$96.41 - $126.61 $4,338 - $5,697	-45 Reduced 81.82%	10 $1,000
Q2 2023 Aug 01, 2023	BUY	$118.5 - $160.53 $1,659 - $2,247	14 Added 34.15%	55 $7,000
Q1 2023 Apr 27, 2023	BUY	$135.66 - $197.02 $5,562 - $8,077	41 New	41 $6,000
Q1 2022 May 05, 2022	BUY	$126.46 - $235.05 $1,896 - $3,525	15 New	15 $3,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hazlett, Burt & Watson, Inc., based on Form 13F filings with the SEC.

Stay updated on Hazlett, Burt & Watson, Inc. with notifications on news.